Literature DB >> 26406957

Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.

Yunsheng Zhao1, Meng Wang1, Chenying Cui1, Lina Zhang1, Fei Liao2, Hongchen Li1, Xia Wu1.   

Abstract

BACKGROUND: The most practical serum biomarker AFP is negative in 80% patients with small tumor in the early stage of primary hepatocellular carcinoma (PHC).
OBJECTIVE: To investigate significance of combined tests of serum golgi glycoprotein 73 (GP73), lens culinaris agglutinin-reactive alpha-fetoprotein (AFP-L3), glypican 3 (GPC3), des-gamma-carboxy prothrombin (DCP), CA199, ferritin (FER) and carcinoembryonic antigen (CEA) in diagnosis of small PHC with negative AFP.
METHODS: A total of 50 cases of small PHC, 60 cases of non-PHC digestive system disorders and 40 cases of healthy controls were collected. Serum GP73, GPC3 and DCP were analyzed by enzyme-1inked immunosorbent assay. AFP-L3 was separated by microspincolumn; the levels of CA199, FER, CEA, AFP-L3 and total AFP were quantified by electrochemiluminescence immunoassays; percentage of AFP-L3 to total AFP was calculated.
RESULTS: Levels of those biomarkers except FER were all significantly different among three groups (P < 0.01). Positive detection rates of seven biomarkers in PHC were higher than other groups (P < 0.01). In individual detection, the highest sensitivity, accuracy rate and area under ROC curve were 72.0%, 86.7% and 0.826 by GP73 and the highest specificity was 98.0% by GPC3. In combined detection with those seven biomarkers, the sensitivity, specificity, accuracy rate and area under ROC curve were 82.0%, 95.0%, 90.1% and 0.884.
CONCLUSIONS: GP73 and AFP-L3 are superior biomarkers to aid the diagnosis of small PHC with negative AFP. The combined detection of biomarkers improved the diagnostic accuracy.

Entities:  

Keywords:  Primary hepatocellular carcinoma; biomarkers; combined detection; diagnosis

Mesh:

Substances:

Year:  2015        PMID: 26406957     DOI: 10.3233/CBM-150508

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  14 in total

1.  A premature proposal for new liver cancer seromarkers.

Authors:  Liu-Cheng Wu; Wen-Feng Gong; Jian-Hong Zhong
Journal:  Tumour Biol       Date:  2016-01-13

2.  ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.

Authors:  Xiaohan Li; Bo Li; Boan Li; Tongsheng Guo; Zhiqiang Sun; Xiaoxi Li; Lin Chen; Weijiao Chen; Peng Chen; Yuanli Mao; Yanjun Zeng
Journal:  Pathol Oncol Res       Date:  2017-08-21       Impact factor: 3.201

3.  Biomarker identification of hepatocellular carcinoma using a methodical literature mining strategy.

Authors:  Nai-Wen Chang; Hong-Jie Dai; Yung-Yu Shih; Chi-Yang Wu; Mira Anne C Dela Rosa; Rofeamor P Obena; Yu-Ju Chen; Wen-Lian Hsu; Yen-Jen Oyang
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

4.  Interaction of MRE11 and Clinicopathologic Characteristics in Recurrence of Breast Cancer: Individual and Cumulated Receiver Operating Characteristic Analyses.

Authors:  Cheng-Hong Yang; Sin-Hua Moi; Li-Yeh Chuang; Shyng-Shiou F Yuan; Ming-Feng Hou; Yi-Chen Lee; Hsueh-Wei Chang
Journal:  Biomed Res Int       Date:  2017-01-04       Impact factor: 3.411

5.  The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma.

Authors:  Bo Li; Boan Li; Tongsheng Guo; Zhiqiang Sun; Xiaohan Li; Xiaoxi Li; Han Wang; Weijiao Chen; Peng Chen; Yuanli Mao
Journal:  Biomed Res Int       Date:  2017-04-30       Impact factor: 3.411

6.  Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray.

Authors:  Min Wu; Haidong Liu; Zhaobo Liu; Chao Liu; Aiying Zhang; Ning Li
Journal:  J Int Med Res       Date:  2018-08-15       Impact factor: 1.671

7.  c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment.

Authors:  Yiming Liu; Sining Zhou; Jieyao Shi; Xiaodi Zhang; Linhui Shentu; Zhi Chen; Linfu Zhou
Journal:  Oncogenesis       Date:  2019-10-07       Impact factor: 7.485

8.  CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.

Authors:  Hua Xiang; Lin Long; Yuanhui Yao; Zhiyong Fang; Zhiming Zhang; Yongjin Zhang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

9.  Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression.

Authors:  Sin-Hua Moi; Yi-Chen Lee; Li-Yeh Chuang; Shyng-Shiou F Yuan; Fu Ou-Yang; Ming-Feng Hou; Cheng-Hong Yang; Hsueh-Wei Chang
Journal:  Cancer Cell Int       Date:  2018-02-09       Impact factor: 5.722

Review 10.  Golgi protein 73 and its diagnostic value in liver diseases.

Authors:  Yanyan Xia; Yuanying Zhang; Mengjiao Shen; Hongpan Xu; Zhiyang Li; Nongyue He
Journal:  Cell Prolif       Date:  2018-10-19       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.